// App-Quantinova.ai

2201 : Triple Positivity of Antiphospholipid Antibody As the Main Thrombotic Factor in a Long-Term Follow-up Study of 98 Asymptomatic Apl-Positive Carriers

Researchers

Presenter

  • Cecile Yelnik

Principal Investigators

  • Elodie Drumez

  • Sylvain Dubucquoi

  • Vincent Sobanski

  • Helene Maillard

  • Alain Duhamel

  • David Launay

  • Eric Hachulla

  • Pierre-Yves Hatron

  • Marc Lambert

Medical Centers

  • CERIM, Universite Lille Nord de France, Lille, France

  • Institut -Immunologie, Centre de Biologie-Pathologie-Genetique, CHRU Lille, Lille, France

  • LIRIC, INSERM UMR , Lille, France

  • Service de Medecine Interne, Centre National de Reference des Maladies Systemiques Rares, Hopital Claude Huriez, CHRU Lille, Lille, France

  • Faculte de Medecine Henri Warembourg, Universite Lille Nord de France, lille, France

  • Faculte de Medecine Henri Warembourg, Universite Lille Nord de France, lille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved